Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
Changes to blood-based biomarkers can be detected before Alzheimer’s symptoms appear, potentially allowing for earlier intervention and more targeted treatment approaches.
Family Medicine/General Practice August 29th 2024
Psychiatrist.com
A 24-year prospective study involving 362 inpatients with borderline personality disorder (BPD) has found that while the prevalence of symptomatic disorders declines over time, the absence of substance use disorders is the strongest predictor of BPD recovery.
Psychiatry August 27th 2024
Psych Congress NP Institute
Expert psychiatric nurse practitioners stress the importance of familiarity with product inserts for each long-acting injectable antipsychotic to effectively manage missed doses in schizophrenia treatment.
Neurology August 27th 2024
Psychiatry Advisor
Erzofri offers a new once-monthly injectable option for treating schizophrenia and schizoaffective disorder, potentially improving medication adherence for some patients.
Geriatrics August 27th 2024
Early aesthetic interventions in Gen Z patients carry both physical and psychological risks, necessitating careful consideration and patient education by healthcare providers.
Dermatology August 21st 2024
Neurology Learning Network
CBTI offers a non-pharmacological approach to treating insomnia, focusing on behavioral changes that can lead to long-term improvements in sleep quality.
Neurology August 14th 2024